EDESA BIOTECH, INC. Fair Value Adjustment of Warrants
EDESA BIOTECH, INC. (EDSA) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-12-15
- EDESA BIOTECH, INC. fair value adjustment of warrants for the quarter ending 2023-09-30 was $0.00.
- EDESA BIOTECH, INC. fair value adjustment of warrants for the quarter ending 2023-06-30 was $0.00.
- EDESA BIOTECH, INC. fair value adjustment of warrants for the quarter ending 2022-09-30 was $0.00.
- EDESA BIOTECH, INC. fair value adjustment of warrants for the quarter ending 2022-06-30 was $0.00.
- EDESA BIOTECH, INC. fair value adjustment of warrants for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- EDESA BIOTECH, INC. fair value adjustment of warrants for fiscal 2022 was $408.06K, a 0.25% increase from fiscal 2021.
- EDESA BIOTECH, INC. fair value adjustment of warrants for fiscal 2021 was $407.02K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $0.00 derived: sum of 2 quarters · filed 2023-12-15 | $0.00 10-K · filed 2023-12-15 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $0.00 derived: sum of 2 quarters · filed 2023-12-15 | $408.06K 10-K · filed 2023-12-15 | |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | $408.06K 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $408.06K 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | -$1.00 derived: sum of 2 quarters · filed 2022-12-16 | $407.02K 10-K · filed 2022-12-16 | |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $407.02K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $407.02K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |